FBI raids San Diego's NexBio

Last week federal investigators raided San Diego-based NexBio, which is developing a powdered inhaler flu treatment called Fludase. Twenty cardboard boxes were removed from the company's offices, although an FBI spokesperson declined to reveal what the agency was looking for. Report

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.